Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Angina, Unstable

• Prasugrel Or Ticagrelor De-escalation in NSTE-ACS
• Safety of Argatroban Infusion in Conduction Disturbances
• Acute Myocardial Infarction and Unstable Angina Patients With PCSK9 Inhibitor Usage Study
• Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome
• Dapagliflozin Effects on Mayor Adverse Cardiovascular Events in Patients With Acute Myocardial Infarction (DAPA-AMI)
• Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris
• Influence of METHoxyflurane on ANtiplatelet Effect of Ticagrelor in Patients With Unstable Angina Pectoris
• Metformin Continuation Versus Interruption Following Coronary Angiography: a Pilot Randomized Controlled Trial
• Trimetazidine in Myocardial Injury After Percutaneous Coronary Intervention in Patients With Angina and Diabetes
• Efficacy and Safety of Low Dose Ticagrelor in Patients With Unstable Angina Pectoris After Coronary Stent Implantation
• Safety and Efficacy of LMWH Versus Rivaroxaban in Chinese Patients Hospitalized With Acute Coronary Syndrome
• Research on the Clinical Effect of Xuefu Zhuyu Decoction in Treating Unstable Angina.
• Research on the Clinical Effect of Shuanghe Decoction in Treating Unstable Angina.
• Effect of Gualou Xiebai Banxia Decoction With Danshen Decoction in Treating Unstable Angina.
• Influence of Naloxone on Ticagrelor Pharmacokinetics and Pharmacodynamics in Patients With Unstable Angina Pectoris on Concomitant Treatment With Morphine
• Influence of Metoclopramide on Ticagrelor Pharmacokinetics and Pharmacodynamics in Patients With Unstable Angina Pectoris on Concomitant Treatment With Morphine
• Crushed Ticagrelor Versus Eptifibatide Bolus + Clopidogrel
• Acute Coronary Syndrome Sri Lanka Audit Project
• The Effect of IV Cangrelor and Oral Ticagrelor Study
• COMBO-Stent in Patients on Chronic Anticoagulant Therapy (COSTA) COSTA-Bleed and COSTA-Outcome Trials
• Comparison of Administration Strategies of Ticagrelor in Patients With Unstable Angina Pectoris, a Pharmacokinetic / Pharmacodynamic Study
• ISAR-DAPT (A Comparative Evaluation of Efficacy and Safety in the 3-Months DAPT Group vs. the 6-Months DAPT Group of Patients Treated With the Coroflex ISAR Stent; A Prospective, Multicenter, Randomized, Open-Label Clinical Trial)
• Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - Coronary Intervention With Next Generation Drug-Eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy (HOST-IDEA) Trial
• Efficacy Study of Nicorandil on Neointima
• Ticagrelor or Prasugrel Versus Clopidogrel in Elderly Patients With an Acute Coronary Syndrome and a High Bleeding Risk: Optimization of Antiplatelet Treatment in High-risk Elderly
• Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction by Biomarkers
• Safety and Efficacy of CMX-2043 for Protection of the Heart and Kidneys in Subjects Undergoing Coronary Angiography
• Efficacy of Vitamin E in Preventing Contrast-Induced Acute Kidney Injury Following Coronary Angiography
• Impact of Ticagrelor on the Endothelial Healing Following Drug-eluting Stent Implantation in the Patients With Acute Coronary Syndrome
• Assessment of Coronary Flow Reserve by Doppler Flow WIre in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Differences Between the Loading Dose of Prasugrel and Ticagrelor .
• Assessment of Coronary Flow Reserve by Doppler Flow Wire in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Differences Between the Loading Dose of Ticagrelor and Clopidogrel
• Danhong Injection in the Treatment of Unstable Angina Pectoris
• An Efficacy and Outcome Study of Supplemental Oxygen Treatment in Patients With Suspected Myocardial Infarction
• Vasoactive and Anti-inflammatory Effects of Prasugrel in Acute Coronary Syndrome
• Atorvastatin for Reduction of Myocardial Damage During Angiography and Its Mechanism Associated With IMR
• DEDICA (Dose of HEparin During Coronary Angioplasty) Trial
• Comparison Between Lidocaine, Dexmedetomidine, and Their Combined Infusion in Subjects Undergoing Coronary Artery Bypass Graft
• The Study of MicroRNA Genomics of Blood Stasis Syndrome and of Coronary Heart Disease
• Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention
• Intensive Statin Therapy in PCI Patient With Acute Coronary Syndrome
• Patients With High-risk Acute Coronary Syndrome Without ST-segment Elevation
• The Effect of Pioglitazone on Neointima Volume and Characteristics Observed by Optical Coherence Tomography (OCT)
• High Dose and Low Dose of Atorvastatin in Patients With Unstable Angina and NSTEMI (Non ST Elevation MI)
• Intensive Statin Treatment in Chinese Coronary Artery Disease Patients Undergoing PCI
• Aggrastat Truncated Length Against Standard Therapies in Percutaneous Coronary Intervention
• Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy
• Comparative Study of ALX-0081 Versus GPIIb/IIIa Inhibitor in High Risk Percutaneous Coronary Intervention (PCI) Patients
• An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome
• Dual Antiplatelet Therapy Tailored on the Extent of Platelet Inhibition
• Beta-cell Function in Glucose Abnormalities and Acute Myocardial Infarction
• Ischemia Driven Enoxaparin Therapy in ACS Presenting as Low Risk (IDEAL)
• Study on Safety and Effectiveness of Three Doses of Argatroban as Anticoagulant in Percutaneous Coronary Intervention (PCI)
• Dalteparin Versus Unfractionated Heparin In Patients With Acute Coronary Syndrome
• Efficiency of a New Therapy to Treat Stenosis of Coronary Vessels in Comparison With Two Already Admitted Therapies
• Intravenous Isosorbide Dinitrate Versus Sublingual Isosorbide Dinitrate for the Relief of Acute Anginal Episodes in Acute Coronary Syndrome (ACS) Patients
• Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for InterventionS
• CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV Events
• Pilot Study of Hemoglobin Based Oxygen Therapeutics in Elective Coronary Revascularization
• A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Patients With Unstable Angina Not Responding to Standard Medical Therapy Who Are Eligible for Coronary Angioplasty
• A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-platelet Therapy, in Patients Undergoing High-risk Coronary Angioplasty
• Serp-1 for the Treatment of Acute Coronary Syndrome
• Protective Effect of EPA on Cardiovascular Events
• Bupropion for Hospitalized Smokers With Acute Cardiovascular Disease
• Abciximab, Clopidogrel and Percutaneous Coronary Intervention in Acute Coronary Syndrome (ISAR-REACT-2)
• Hexadecasaccharide (SR123781A) in Patients With Unstable Angina or Non-ST-Segment Elevation Myocardial Infarction
• Omega-3 Fatty Acids to Improve Depression and Reduce Cardiovascular Risk Factors
• Comparison of Angiomax Versus Heparin in Acute Coronary Syndromes (ACS)
• IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium.
• ARISE - Aggressive Reduction of Inflammation Stops Events
• SYNERGY: Open Study of Enoxaparin Versus Unfractionated Heparin in Patients With Acute Coronary Syndromes
• Postmenopausal Hormone Therapy in Unstable Angina